Paradigm Biopharmaceuticals (ASX:PAR) - Webinar Presentation

Company Presentations

by Finance News Network

Paul Rennie - Founder and Managing Director - Paradigm Biopharmaceuticals Limited (ASX:PAR) is a global biopharmaceutical company. Its current focus is a drug for the treatment of osteoarthritis.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?